Different types of endocarditis after transcatheter aortic valve implantation. Issue 6 (22nd April 2019)

• Record Type: Journal Article
• Authors: Scisło, Piotr; Grodecki, Kajetan; Wilimski, Radosław; Rymuza, Bartosz; Kochman, Janusz; Opolski, Grzegorz; Huczek, Zenon
• Is Part Of: Echocardiography. Volume 36:Issue 6(2019)
• Page Start: 1132
• Page End: 1138
• Publication Date: 2019-04-22
• Subjects: infective endocarditis -- prostetic valve endocarditis -- transcatheter aortic valve implantation -- transcatheter aortic valve replacement; Echocardiography -- Periodicals; Echocardiography -- Periodicals; 616.1207543
• DOI: 10.1111/echo.14346
• Languages: English
• ISSNs: 0742-2822

Abstract

Abstract : Introduction: Infective endocarditis (IE) may take different faces in patients after transcatheter aortic valve implantation (TAVI). Objectives: The primary aim of this study was to describe echocardiographic and clinical characteristics of TAVI's patients suffered from IE. Methods: In a single‐center, retrospective study we analyzed 311 consecutive patients treated with TAVI for severe aortic stenosis between 2010 and 2018. Results: According to modified Duke criteria, we confirmed IE in 2.2% of the cohort, however PVE of TAVI's valve in 1.2% only; rest of the group suffered from CDRiE and IE of the mitral valve. In PVE's group vegetations were localized inside the frame with or without bioprosthesis moderate stenosis or regurgitation. Only 1 pts developed significant TAVI's bioprosthesis' paravalvular leak. We observed no native aortic anulus involvement. Mortality rate in the PVE‐TAVI's group was 75% regardless of the type of treatment. Conclusions: The above findings show that IE following TAVI is a serious complication and various scenarios (also CDRiE and native valve IE) should be considered.